Loading...
NPI 1740240753 · Carlsbad, CA · Clinical Medical Laboratory
Customize your policy alerts
Get alerted when relevant policies change without checking for updates manually.
Monitor payer policy activity
Neogenomics Laboratories Inc is a clinical medical laboratory provider located in Carlsbad, California. This profile covers 21 Medicare and 35 Medicaid CPT/HCPCS procedure codes, with claims volume, average reimbursement, and total revenue by code, benchmarked against other providers billing the same services.
Provider details (source: NPPES NPI Registry)
| Field | Value |
|---|---|
| Entity Type | Organization |
| Organization | Neogenomics Laboratories Inc |
| Address | 2173 Salk Ave Ste 300 |
| City | Carlsbad |
| State | CA |
| ZIP | 92008 |
| Taxonomy | Clinical Medical Laboratory |
| NPI Enumerated | March 24, 2006 |
Lifetime revenue by payer source (source: CMS Medicare & Medicaid claims data)
| Payer Source | Total Paid |
|---|---|
| Medicare | $2.9M |
| Medicaid | $1.4M |
Medicare revenue breakdown by CPT/HCPCS procedure code.
View: Bar Chart1 / 2
The CPT/HCPCS codes generating the most Medicare revenue for this provider.
21 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| 88374 | The lab analyst applies a single multiplex in situ hybridization probe stain on a slide or slides prepared from a single patient specimen, such as tumor tissue. The lab analyst processes the slides… | 21,430 | $40 | $750.2K |
| 88189 | The clinician, typically a pathologist, interprets flow cytometry results of 16 or more markers. | 7,430 | $70 | $505.1K |
| 88341 | The lab analyst applies an additional single antibody stain on a slide or slides prepared from the same patient specimen as the initial antibody stain, such as tumor tissue. Then a qualified… | 16,220 | $20 | $372.9K |
| 88377 | The lab analyst applies a single multiplex in situ hybridization probe stain on a slide or slides prepared from a single patient specimen, such as tumor tissue. Then a qualified provider, typically a… | 5,000 | $50 | $259.9K |
| 88291 | A qualified provider, typically a pathologist, submits an interpretation and report of cytogenetic and molecular cytogenetic testing commonly performed by lab analysts. | 6,350 | $30 | $171.6K |
| 88264 | The analyst performs a chromosome analysis and analyzes 20 to 25 cells. The analysis includes counting the number of chromosomes in each cell and preparing a karyotype for each cell examined. | 930 | $140 | $131.3K |
| 88361 | The lab analyst applies a single antibody stain on a slide or slides prepared from a single patient specimen, such as tumor tissue. The lab analyst processes the slides using computer assisted… | 3,410 | $40 | $122.6K |
| 88305 | The physician, typically a pathologist, performs a level IV examination of a surgical pathology specimen. The examination includes accessioning the specimen into the lab, which involves formally… | 4,010 | $30 | $120.3K |
| 85097 | The clinician, typically a pathologist, interprets a smear prepared from a sample of bone marrow. | 2,250 | $50 | $119.4K |
| 88342 | The lab analyst applies an initial single antibody stain on a slide or slides prepared from a single patient specimen, such as tumor tissue. Then a qualified provider, typically a pathologist,… | 3,550 | $30 | $102.9K |
Showing 1–10 of 21
How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 21 CPT/HCPCS codes.
View: State1 / 2
Full comparison — all codes billed, vs. state median
21 rows
| CPT/HCPCS Code | Rank | Provider Count | Median Claims | Avg Paid | Average Revenue |
|---|---|---|---|---|---|
| 88120 | 10 | 20 | 120 | $400 | $122.8K |
| 88264 | 2 | 10 | 70 | $140 | $58.7K |
| 88374 | 2 | 60 | 80 | $70 | $56.3K |
| 88305 | 97 | 1,580 | 450 | $40 | $51.3K |
| 88377 | 2 | 100 | 40 | $140 | $41.6K |
| 88291 | 2 | 20 | 90 | $30 | $25.9K |
| 88361 | 2 | 50 | 100 | $50 | $23.7K |
| 88189 | 1 | 150 | 90 | $70 | $19.3K |
| 88341 | 2 | 920 | 260 | $40 | $15.7K |
| 88342 | 4 | 1,000 | 120 | $50 | $11.2K |
Showing 1–10 of 21
Medicaid revenue breakdown by year and by CPT/HCPCS procedure code, including monthly billing trends and the top codes driving revenue.
View: By Year1 / 3
Every CPT/HCPCS code this provider has billed to Medicaid, with claims volume, average payment, and total revenue.
35 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high… | 3,180 | $90 | $296.1K |
| 88377 | The lab analyst applies a single multiplex in situ hybridization probe stain on a slide or slides prepared from a single patient specimen, such as tumor tissue. Then a qualified provider, typically a… | 2,420 | $80 | $191K |
| 88189 | The clinician, typically a pathologist, interprets flow cytometry results of 16 or more markers. | 7,090 | $20 | $163K |
| 88374 | The lab analyst applies a single multiplex in situ hybridization probe stain on a slide or slides prepared from a single patient specimen, such as tumor tissue. The lab analyst processes the slides… | 3,030 | $50 | $145.6K |
| 88185 | The lab analyst performs the technical component of a flow cytometry procedure using cell surface, cytoplasmic, or nuclear markers to characterize cells and aid clinicians in diagnosing patients with… | 1,470 | $90 | $133.6K |
| 88264 | The analyst performs a chromosome analysis and analyzes 20 to 25 cells. The analysis includes counting the number of chromosomes in each cell and preparing a karyotype for each cell examined. | 1,360 | $60 | $85.9K |
| 88341 | The lab analyst applies an additional single antibody stain on a slide or slides prepared from the same patient specimen as the initial antibody stain, such as tumor tissue. Then a qualified… | 1,500 | $50 | $73.4K |
| 81450 | The lab analyst performs a genomic sequence analysis panel to evaluate the patient specimen, such as blood or bone marrow, for DNA and possibly RNA alterations in five to 50 genes known to impact… | 580 | $90 | $53.3K |
| 85097 | The clinician, typically a pathologist, interprets a smear prepared from a sample of bone marrow. | 1,400 | $30 | $37.7K |
| 88313 | The lab analyst performs the technical lab steps to stain a specimen for Group II identification, for example an iron stain or trichrome stain. A qualified provider, typically a pathologist,… | 1,450 | $20 | $31.9K |
Showing 1–10 of 35
How this provider's Medicaid billing volume and revenue compare to other California providers billing the same CPT/HCPCS codes.
Full comparison — all codes billed, vs. California median
35 rows
| CPT/HCPCS Code | Description | Rank | Provider Count | Median Claims | Avg Paid | Average Revenue |
|---|---|---|---|---|---|---|
| 81479 | Use 81479 to report a molecular pathology procedure that does not have a specific code. | 40 | 50 | 500 | $160 | $1.1M |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high… | 207 | 750 | 950 | $50 | $890K |
| 81455 | The lab analyst performs a genomic sequence analysis panel to evaluate the patient specimen, such as tumor tissue or bone marrow, for DNA and possibly RNA alterations in 51 or more genes known to… | 8 | 10 | 80 | $660 | $439.2K |
| 88374 | The lab analyst applies a single multiplex in situ hybridization probe stain on a slide or slides prepared from a single patient specimen, such as tumor tissue. The lab analyst processes the slides… | 2 | 10 | 90 | $90 | $371.2K |
| 88185 | The lab analyst performs the technical component of a flow cytometry procedure using cell surface, cytoplasmic, or nuclear markers to characterize cells and aid clinicians in diagnosing patients with… | 10 | 40 | 220 | $140 | $354.7K |
| 88381 | A clinician, typically a pathologist, performs a manual microdissection of a patient’s specimen, such as a biopsy or tissue preserved from a previous case. | 10 | 10 | 410 | $80 | $259.5K |
| 88377 | The lab analyst applies a single multiplex in situ hybridization probe stain on a slide or slides prepared from a single patient specimen, such as tumor tissue. Then a qualified provider, typically a… | 2 | 10 | 110 | $100 | $252.6K |
| 88305 | The physician, typically a pathologist, performs a level IV examination of a surgical pathology specimen. The examination includes accessioning the specimen into the lab, which involves formally… | 369 | 830 | 880 | $40 | $195.6K |
| 88361 | The lab analyst applies a single antibody stain on a slide or slides prepared from a single patient specimen, such as tumor tissue. The lab analyst processes the slides using computer assisted… | 3 | 10 | 260 | $70 | $186.9K |
| 81403 | The lab analyst performs the technical lab test to complete one of the specific genetic analyses listed in this Tier 2, Level 4 molecular pathology code. | 15 | 20 | 420 | $30 | $146K |
Showing 1–10 of 35
Other providers in the same ZIP code as Neogenomics Laboratories Inc, ranked by combined Medicare and Medicaid revenue.
| Provider | State | Taxonomy | Medicare Revenue | Medicaid Revenue |
|---|---|---|---|---|
| Breg, Inc. | CA | Prosthetic/Orthotic Supplier | $0 | $49.6M |
| Agency Personal Care | CA | In Home Supportive Care Agency | $0 | $25.5M |
| Glenn Balfour | CA | Neurology Physician | $1M | $40.4K |
| Anuradha Kanungo | CA | Anatomic Pathology & Clinical Pathology Physician | $444.5K | $0 |
| Mary Headley | CA | Family Nurse Practitioner | $348.4K | $0 |
| Martin Apt | CA | Psychiatric/Mental Health Nurse Practitioner | $177.9K | $0 |
| Marianna Siksay | CA | Family Medicine Physician | $109.7K | $0 |
| Kean Ganan | CA | Anesthesiology Physician | $105.6K | $0 |
| Ritvik Mehta | CA | Otolaryngology/Facial Plastic Surgery Physician | $91K | $0 |
| Vishal Banthia | CA | Otolaryngology Physician | $39.9K | $0 |
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.